Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 16 04:00PM ET
7.92
Dollar change
-0.28
Percentage change
-3.41
%
IndexRUT P/E- EPS (ttm)-1.76 Insider Own0.54% Shs Outstand25.68M Perf Week-9.07%
Market Cap196.73M Forward P/E- EPS next Y-0.79 Insider Trans0.55% Shs Float24.71M Perf Month-15.57%
Income-44.82M PEG- EPS next Q-0.48 Inst Own29.76% Short Float6.42% Perf Quarter-55.20%
Sales50.70M P/S3.88 EPS this Y-20.40% Inst Trans-12.13% Short Ratio6.15 Perf Half Y-41.03%
Book/sh1.26 P/B6.27 EPS next Y53.09% ROA-47.18% Short Interest1.59M Perf Year-34.81%
Cash/sh2.74 P/C2.89 EPS next 5Y- ROE-81.39% 52W Range7.51 - 21.70 Perf YTD-42.27%
Dividend Est.- P/FCF- EPS past 5Y-82.76% ROI-58.66% 52W High-63.51% Beta1.51
Dividend TTM- Quick Ratio6.64 Sales past 5Y45.68% Gross Margin84.96% 52W Low5.46% ATR (14)0.71
Dividend Ex-Date- Current Ratio7.25 EPS Y/Y TTM-67.02% Oper. Margin-255.88% RSI (14)30.14 Volatility10.65% 7.20%
Employees207 Debt/Eq1.37 Sales Y/Y TTM35.44% Profit Margin-88.41% Recom1.90 Target Price18.26
Option/ShortYes / Yes LT Debt/Eq1.35 EPS Q/Q-98.93% Payout- Rel Volume1.39 Prev Close8.20
Sales Surprise0.22% EPS Surprise-111.84% Sales Q/Q5.25% EarningsMay 13 AMC Avg Volume257.79K Price7.92
SMA20-8.51% SMA50-36.26% SMA200-42.44% Trades Volume358,251 Change-3.41%
Date Action Analyst Rating Change Price Target Change
Apr-11-24Downgrade BTIG Research Buy → Neutral
Jun-27-23Initiated Cantor Fitzgerald Overweight $23
Mar-02-21Initiated Piper Sandler Overweight $27
Aug-27-20Initiated BofA Securities Buy $42
Apr-21-20Initiated Oppenheimer Outperform $9
Mar-03-20Initiated BTIG Research Buy $10
May-16-24 06:30PM
May-14-24 08:57AM
03:04AM
May-13-24 09:55PM
04:01PM
09:16AM Loading…
May-12-24 09:16AM
Apr-15-24 05:05PM
Apr-10-24 05:11PM
Feb-29-24 04:02PM
09:00AM
Feb-23-24 10:45AM
09:01AM
Feb-22-24 04:45PM
04:01PM
Feb-01-24 04:10PM
04:01PM Loading…
Jan-10-24 04:01PM
09:01AM
Jan-04-24 09:00AM
Dec-04-23 09:00AM
Nov-21-23 04:15PM
Nov-20-23 04:15PM
Nov-10-23 03:04PM
Nov-09-23 04:01PM
09:00AM
Oct-19-23 04:05PM
Oct-18-23 09:00AM
Oct-02-23 02:37PM
Sep-25-23 08:00AM
Sep-21-23 04:30PM
Sep-06-23 06:45PM
08:00AM Loading…
Aug-14-23 08:00AM
Aug-12-23 09:44AM
Aug-10-23 04:01PM
Jul-20-23 04:05PM
Jul-16-23 07:34PM
Jul-14-23 06:59AM
Jun-29-23 06:21PM
Jun-26-23 08:00AM
Jun-22-23 07:05AM
Jun-16-23 02:47PM
Jun-15-23 04:05PM
Jun-08-23 02:25PM
Jun-07-23 08:00PM
May-25-23 05:15PM
May-15-23 06:31PM
May-11-23 04:12PM
May-04-23 09:40PM
Apr-21-23 08:50AM
Apr-20-23 04:30PM
10:14AM
Apr-19-23 12:00PM
Apr-13-23 05:35PM
Apr-12-23 12:34PM
Apr-08-23 07:24PM
Apr-04-23 08:50AM
Mar-30-23 08:42AM
Mar-23-23 04:30PM
Mar-16-23 04:30PM
08:50AM
Mar-14-23 09:55AM
Mar-02-23 04:30PM
Feb-28-23 08:50AM
Feb-27-23 08:00AM
Feb-26-23 06:12AM
Feb-25-23 07:20PM
Feb-23-23 04:01PM
Feb-09-23 04:05PM
Feb-05-23 08:43PM
Jan-30-23 04:54AM
Jan-19-23 04:05PM
Dec-19-22 08:00AM
Dec-12-22 09:11PM
09:15AM
Nov-21-22 04:01PM
Nov-16-22 09:00PM
Nov-15-22 09:55AM
Nov-13-22 05:03PM
Nov-10-22 04:01PM
Nov-09-22 06:45PM
Nov-03-22 08:15PM
04:39PM
Oct-20-22 04:01PM
Sep-28-22 07:06PM
Sep-23-22 06:40PM
Sep-19-22 05:27PM
Sep-13-22 04:11PM
Sep-12-22 04:23PM
Sep-01-22 08:00AM
Aug-27-22 06:14PM
Aug-17-22 04:50PM
Aug-11-22 04:06PM
04:05PM
Aug-01-22 02:18PM
Jul-25-22 04:01PM
Jun-07-22 09:55AM
May-12-22 04:14PM
May-09-22 04:01PM
Apr-28-22 04:01PM
Apr-21-22 09:00AM
Apr-04-22 08:00AM
AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company was founded in December 1992 and is headquartered in Valencia, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
O'Toole David DCFOFeb 28 '24Buy17.391,25021,73818,734Feb 28 04:04 PM
CORBETT JAMESCEODec 26 '23Sale13.291,44519,20411,580Dec 27 05:02 PM
COOK JEREMY CURNOCKDirectorDec 13 '23Sale12.272,51830,89620,596Dec 14 05:01 PM
O'Toole David DCFODec 12 '23Buy12.4595011,82817,484Dec 12 04:37 PM
O'Toole David DCFODec 01 '23Buy10.685005,34016,534Dec 04 07:06 PM
O'Toole David DCFONov 21 '23Buy10.282,00020,56015,000Nov 21 04:15 PM
O'Toole David DCFONov 16 '23Buy12.151,00012,15012,000Nov 16 02:38 PM
O'Toole David DCFONov 15 '23Buy13.251,00013,25011,000Nov 15 04:31 PM
O'Toole David DCFONov 15 '23Buy12.451,00012,45013,000Nov 16 02:38 PM
O'Toole David DCFONov 14 '23Buy12.881,00012,88010,000Nov 15 04:31 PM
Shiroma DonnaGeneral CounselAug 21 '23Sale15.844,19366,41742,257Sep 08 05:36 PM
O'Toole David DCFOAug 16 '23Buy17.052,00034,1109,000Aug 16 05:57 PM
O'Toole David DCFOAug 15 '23Buy17.935,00089,6407,000Aug 15 04:43 PM
O'Toole David DCFOJun 20 '23Buy16.151,00016,1502,000Jun 21 06:50 PM